---
schema_version: "secwatch.filing_event.v1"
accession: "0001824293-26-000006"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2026-01-09T23:59:59+00:00"
generated_at: "2026-05-16T11:05:29.751645+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# GRI Bio increases ATM offering capacity to $7.38M, waives Dec 2025 SPA restrictions

## Summary
- Increased ATM capacity by up to $7.38M in common stock; $6.17M already sold under the program.
- Waived certain provisions of the Dec 11, 2025 securities purchase agreement to permit additional ATM issuances.
- At-the-market offering agreement with H.C. Wainwright & Co. dated May 20, 2024 remains in effect.

## SEC filing metadata
- accession: 0001824293-26-000006
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2026-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000182429326000006/0001824293-26-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000182429326000006/val-20260109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001824293-26-000006
- JSON: https://secwatch.observer/filing/0001824293-26-000006.json
- Plain text: https://secwatch.observer/filing/0001824293-26-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.